Scientists say they will have 'complete cure for cancer within a year'

Israeli scientists claim they'll have cancer cure in a year

"We believe we will offer in a year's time a complete cure for cancer", said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd (AEBi), The Jerusalem Post published.

Dan Aridor, chairman of Accelerated Evolution Biotechnologies Ltd. (AEBi), told the Jerusalem Post that a possible cure could be ready within a year and would have nearly no side effects.

He added to MailOnline: "The Israeli scientists" reports of a "universal cancer cure" have not been substantiated through publications in peer-reviewed articles, nor have they been demonstrated in human clinical trials, and their claims should be met with extreme skepticism'.

"Unfortunately, we must be aware that this is far from proven as an effective treatment for people with cancer, let alone a cure".

The treatment will eventually be personalised and a specific cocktail of the drugs will be given to patients based on their type of cancer, Dr Morad told the newspaper.

But cancer experts say it sounds too good to be true, particularly in light of International Agency for Research on Cancer reports showing an estimated 18.1 million new cancer cases are diagnosed worldwide each year. First, they had to identify why other cancer-killing drugs and treatments were not working.

The treatment will not be affected by mutations by using at least three targeting peptides on the same structure with a strong toxin.

Called MuTaTo (multi-target toxin), researchers said the drug is essentially "on the scale of a cancer antibiotic-a disruption technology of the highest order".

It could also reduce the sickening side-effects of most cancer treatments, according to Morad.

Morad said the company's initial efforts involved attempting to find "individual novel peptides for specific cancers". "The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically within the number of targets used". Moreover, since the peptides will be killing all the cancerous cells, there's little to no chance of cancer coming back once the peptide has done its job.

"Instead of attacking receptors one at a time, we attack receptors three at a time, Morad told The Jerusalem Post".

Patients would likely be able to stop treatment after several weeks and not need a drug cocktail throughout their lives, according to the scientists.

Aridor concluded, "Our results are consistent and repeatable".

Related:

Comments


Other news